Trials / Completed
CompletedNCT05096026
Effect of Electronic and Mail Outreach From Primary Care Physicians for COVID-19 Vaccination Among Elderly Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8,287 (actual)
- Sponsor
- Kaiser Permanente · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
This randomized controlled trial tested the effect of culturally tailored and standard electronic secure messages and mailings from patients' primary care physicians to encourage COVID-19 vaccination among adults aged 65 and older.
Detailed description
This randomized controlled trial tested the effect of culturally tailored and standard electronic secure messages and mailings from patients' primary care physicians to encourage COVID-19 vaccination among adults aged 65 and older. Patients who had not received a COVID-19 vaccination or appointment after previous outreach attempts were randomized to receive (a) an electronic secure message and/or mail outreach from their PCP, (b) similar outreach with additional culturally tailored content, or (c) usual care. The primary outcome was receipt of COVID-19 vaccination during the 8 weeks after the initial study outreach date.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Standard PCP Outreach | These patients were sent two study outreach messages. Study Outreach 1 was an electronic secure message sent on behalf of the PCP, encouraging COVID-19 vaccination and designed based on behavioral science principles. Letters were sent to patients who had not signed up for the electronic health record portal. Study Outreach 2 was a postcard sent to all patients who had not been vaccinated or made an appointment by four weeks after Study Outreach 1. |
| BEHAVIORAL | Culturally Tailored PCP Outreach | These patients were sent messages similar to those in Standard PCP Outreach, but with additional culturally tailored content and photos. |
Timeline
- Start date
- 2021-03-29
- Primary completion
- 2021-05-20
- Completion
- 2021-08-31
- First posted
- 2021-10-27
- Last updated
- 2021-10-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05096026. Inclusion in this directory is not an endorsement.